secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucy Scientific Discovery, Inc. (—)
CIK:        0001865127
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001213900-24-021841
Event type: m_and_a
Sentiment:  negative
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Lucy Scientific terminates Bluesky Biologicals amalgamation agreement due to missing audited financials
--------------------------------------------------------------------------------

- Terminated Amalgamation Agreement with Bluesky Biologicals on March 5, 2024, per Article 6.1.
- Reason: Bluesky failed to timely provide audited financial statements, as required under the agreement.
- Original agreement dated September 12, 2023, for a three-cornered amalgamation involving Lucy issuing securities.
- Either party could terminate if conditions not met by December 31, 2023; Lucy exercised that right.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865127/000121390024021841/0001213900-24-021841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865127/000121390024021841/ea0201661-8k_lucy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-021841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer